Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001415889-24-000769

CHIEF EXECUTIVE OFFICER sold 4,539 shares at $6.73 ($30,547)

  • CHIEF EXECUTIVE OFFICER acquired 14,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2024-01-04 Grant or award +14,300 290,854 D: show line 1 in the form
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2024-01-04 Sale −4,539 $6.73 $30,547 286,315 D: show line 2 in the form
Open-market sales · 4,539 sh · avg $6.73 · $30,547

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2024-01-04 Grant or award · Stock Option (right to buy) +64,500 64,500 D: show line 3 in the form
Loading xslF345X05/form4-01052024_090140.xml…